Filter
213
Filtered Results: 213
Text search:
dyslipidemia
Featured
Recommendations
17
New Publications
64
Language
Document type
No document type
114
Guidelines
46
Studies & Reports
39
Strategic & Response Plan
5
Manuals
4
Training Material
3
Infographics
1
Fact sheets
1
Countries / Regions
India
17
Global
13
Paraguay
12
Philippines
10
Chile
8
Indonesia
8
Kenya
7
Latin America and the Carribbean
5
Venezuela
4
Tanzania
4
South Africa
4
Ethiopia
4
Mozambique
3
Western and Central Europe
3
North America
3
Brazil
3
Colombia
2
Benin
2
Nigeria
2
Peru
2
Africa
2
Asia
2
Argentina
2
Zambia
2
Eswatini/ Swaziland
2
Nepal
1
El Salvador
1
Ghana
1
Malawi
1
USA
1
Congo, Democratic Republic of
1
West and Central Africa
1
East and Southern Africa
1
Bolivia
1
Bangladesh
1
Eastern Europe
1
Namibia
1
Authors & Publishers
Publication Years
Category
Countries
105
Clinical Guidelines
39
Public Health
37
Women & Child Health
8
Capacity Building
7
Key Resources
1
Toolboxes
NCDs
45
HIV
17
Mental Health
13
COVID-19
5
Planetary Health
4
Pharmacy
4
Refugee
2
Disability
1
Caregiver
1
NTDs
1
AMR
1
This is an abridged version of the 2019 Standards containing the evidence-based recommendations most pertinent to primary care. The tables and figures have been renum-bered from the original document to match this version. The complete 2019 Standards of Care do...
Kenya: Guidelines on use of antiretroviral drugs for treating and preventing HIV infection
recommended
2018 Edition
The resources provide both the older as well as the updated Operational Guidelines for antiretroviral therapy centres, including administrative issues, functions and establishment of centres, reporting and recording tools, measures to improve retention in HIV care, supply chain management of drugs a...
Organizing and Delivering High Quality Care for Chronic Noncommunicable Diseases in the Americas
Obesity and diabetes are affecting the peoples of the Americas at high and increasing rates. National surveys demonstrate that obesity is increasing in prevalence among all age groups; 7% to 12% of children under 5 years old and
one-fi fth of adolescents are obese, while rates of overweight and obe...
Handbook of COVID-19 Prevention and Treatment
recommended
Handbook of COVID-19 Prevention and Treatment, expecting to share their invaluable practical advice and references with medical staff around the world. This handbook compared and analyzed the experience of other experts in China, and provides good reference to key departments such as hospital infect...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Diabetes mellitus (DM) is a global epidemic with significant morbidity. Diabetic
retinopathy (DR) is the specific microvascular complication of DM and affects 1 in 3 persons with DM. DR remains a leading cause of vision loss in working adult populations. Patients with severe levels of DR are report...
This open access book not only describes the challenges of climate disruption, but also presents solutions. The challenges described include air pollution, climate change, extreme weather, and related health impacts that range from heat stress, vector-borne diseases, food and water insecurity and ch...
Guidelines on obstructive sleep apnea in India.
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
Chagas disease poses a public health problem in Latin America, and the electrocardiogram is a crucial tool in the diagnosis and monitoring of this pathology. In this context, the aim of this study was to quantify the change in the ability to detect electrocardiographic patterns among healthcare p...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
Curr Opin Pharmacol . 2022 Apr;63:102203.doi: 10.1016/j.coph.2022.102203. Epub 2022 Feb 11.
The COVID-19 pandemic has widespread economic and social effects on Latin America (LA) and the Caribbean (CA). This region, which has a high prevalence of chronic diseases, has been one of the most affected...
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f...
